The 5' ends of all human immunodeficiency virus type I (HIV-1) transcripts have the potential to coordinately regulate translation of HIV-1 mRNAs. Conflicting observations of the translations! impact of these sequences in various systems stimulated these analyses of translation in reticulocyte lysates. We report a sensitive, rapid, quantitative, and inexpensive cell-free translation assay in which translational efficiency is monitored by enzymatic assay of the translation products. Using this assay and conventional radlolabeling assays, we demonstrate that the HIV-1 transcript leader inhibits downstream translation and that the stem-loop structure is required. Under our assay conditions, this Inhibition occurs predominantly in els and is not mediated by the 68 kD, interferonInduced, double-stranded RNA-activated kinase (p68). However, under other assay conditions the HIV-1 leader may activate p68 and inhibit translation in trans. We show that variation between individual preparations of cell-free extracts can dramatically alter the magnitude of the translational inhibition by the HIV-1 leader. Further, we provide evidence that a heat-labile factor Is required for efficient translation of transcripts containing the HIV-1 leader. These observations provide a foundation for identifying factors required for translation of HIV-1 transcripts.
INTRODUCTION
Investigations of the molecular biology of human immunodeficiency virus, type I (HIV-I) have revealed diverse mechanisms responsible for controlling the kinetics and abundance of viral gene expression (reviewed in 1). Among these, the interactions of the HIV-1 transactivator protein Tat with sequences at the 5' end of HTV RNA, known as TAR, have been the subject of numerous studies (reviewed in 2,3). Although some details are still not resolved, the interaction of Tat and TAR clearly results in a dramatic increase in the abundance of HTV-1 transcripts.
In addition to mediating transactivation by Tat, sequences at the 5' end of HIV-1 RNA, being present on all spliced and unspliced HTV-1 transcripts, have the potential to coordinately modulate the posttranscriptional expression of viral genes. In fact, in cell-free translation extracts and in Xenopus oocytes, the HTV-1 transcript leader profoundly inhibits translation (47). At least two distinct mechanisms may be involved in this effect. Some studies have revealed that RNA molecules containing the HTV-1 leader can inhibit translation by activating the 68 kD interferon-induced double-stranded-RNA-activated kinase (p68 kinase, also known as dsl or DAI; 5, 7, 8) . However, others have reported that molecules containing TAR may block activation of the p68 kinase (9) . The HTV-1 leader has also been reported to inhibit cell-free translation in cis by a mechanism independent of p68 kinase (7) .
HTV-1 Tat activates translation of HTV-1 leader-containing mRNAs in some analyses. In Xenopus oocytes, the HTV-1 leader dramatically inhibits translation unless the RNA is modified in the nucleus in the presence of Tat (6, 10, 11) . While Tat has also been reported to augment translation of HIV-1 leader mRNAs in RRL (7) it does not seem to alter translation of HIV-1 leadercontaining RNAs in primate cells (12) . Tat may also indirectly increase cellular translation by downregulating expression of p68 kinase (13) .
While the magnitude of the inhibitory effect of the HIV-1 leader is quite variable, most reports have revealed a greater effect in cell-free translation systems (4, 5, 7) than in intact cells (12, 14, 15) . To elucidate the basis for the variable translational impact of the HIV-1 leader in different systems, we investigated the influence of HIV-1 leader on translation in rabbit reticulocyte lysates (RRL) using a combination of a conventional 35 S-methionine labeling assay and a new enzymatic assay of translational efficiency. We report that under our assay conditions, the HTV-1 leader inhibits downstream expression predominantly in cis, independent of p68 kinase, and that diis effect requires the stem-loop structure of the HTV-1 leader. Although we observe only a weak trans inhibitory effect of the HTV-1 leader, other assay conditions may elicit a stronger p68 kinase-mediated, trans effect. Notably, we find that the magnitude of the inhibitory effect leader varies dramatically among different lots of cell-free lysate. Further, we provide evidence that a heat-labile factor(s) is necessary for efficient translation of HTV-1 leader-containing RNA.
MATERIALS AND METHODS Plasmids
Insertion of a HindHI/BamHI fragment from pEQ3 (16) , containing the lacZ gene, into HindHI/BamHI digested pBS + (Stratagene) resulted in pEQ4 in which /3-gal transcripts without HTV-1 leader sequences were expressed from the T3 promoter. pEQ292 resulted from insertion of the same HindHI to BamHI fragment into Hindm/BamHI sites of pSP64TARCAT (4; provided by Nahum Sonenberg), replacing the CAT reading frame with that of /9-gal. A Bglll collapse of pEQ292 resulted in pEQ293 in which HTV-1 sequences from +25 to +83 were deleted. The 3.6 kb Hindm/BamHI fragment from pEQ241 (15) containing HIV-1 sequences from +83 to +242 fused to /3-gal was inserted into Hindm/BamHI sites of pSP64TARCAT (replacing the CAT gene) yielding pEQ306. Thus, transcripts expressed from SP6 promoter in pEQ293, pEQ292, and pEQ306 contained HTV-I sequences from +1 to +25, +83, and +282, respectively, fused to /3-gal (Fig. 1) .
Plasmids pEQ390, pEQ389, and pEQ388 containing mutations in the HTV-I TAR stem-loop structure (Fig. 4) were constructed by inserting /3-gal as a Hindm/BamHI fragment from pEQ3 into HindHI/BamHI sites of TARI/ffl, TARI'/TH' and TARI/m/ r/m'(8; provided by Nahum Sonenberg and Michael Katze), respectively.
The Hindm to BamHI fragment containing the CAT gene from pSP64TARCAT was inserted into the Hindm/BamHI sites of pBS + , resulting in pEQ319.
In vitro synthesis of RNA Plasmid DNA, prepared by alkaline lysis and banding twice in CsCl (17) , was digested with either BamHI or ApaLI then purified using Geneclean (Bio 101, La Jolla, CA) following agarose gel electrophoresis. RNA was transcribed in a reaction containing 40 mM Tris-HCl pH7.9, 6 mM MgCl 2 , 4 mM spermidine, 100 /xg/ml BSA, 10 mM DTT, 800 units/ml RNAsin (Promega Corporation, Madison, WT), 1 mM ATP, CTP, and UTP, 0.1 mM GTP, 1 mM m 7 GpppG (New England Biolabs, Beverly, MA), and 2-5 /tg DNA template in the presence of 100 /iCi/ml 3 H-UTP and 800 units/ml T3 polymerase (Boehringer Mannheim Biochemicals, Indianapolis, IN) or 400 units/ml SP6 polymerase (Bethesda Research Laboratories, Gaithersburg, MD). After 1 h at 37°C, another equal quantity of RNA polymerase was added, and the reaction continued for an additional 1 h. After the addition of RNAse-free DNAse I (Boehringer Mannheim Biochemicals) to 1400 units/ml for 15', 37°C, the RNA was purified by phenol:chloroform extraction and passed through a sephadex G-50 spin column. Following ethanol precipitation in potassium acetate, the RNA was resuspended in water and stored at -75°C. The RNA concentration was determined by measuring 3 H incorporation, and the integrity of the RNA was verified by Northern blot analysis.
Cell-free translation assays
The enzymatic cell-free translation assay (TVT-MUG) used either lot A (# 96101) or lot B (# 07490) of micrococcal nuclease treated rabbit reticulocyte lysate (RRL, Promega Corporation). RNA was added to 12.5 /d reactions containing 70% RRL, 20 /iM unlabeled amino acids (each, including methionine), and 800 units/ml RNAsin. After translation at 30°C for 60', 8 reaction volumes of 60 mM Na 2 HPO 4 -7H 2 O, 40 mM NaH 2 PO 4 H 2 O, 10 mM KC1, 1 mM MgSO 4 -7H 2 O, 50 mM 2-mercaptoethanol, and 1 mg/ml BSA containing 1 % DMSO and 0.44 mM of the /3-gal substrate methylumbelliferyl-/3-D-galactoside (MUG, Sigma Chemical Co.) were added. After incubation for 60' at 30°C, a 10 /J aliquot was dequenched by dilution into 190 /tl of 1.5% H 2 O 2 and 1 N NaOH for 5' at room temperature, and fluorescence was measured using a Microfluor microfluorimeter (Dynatech Laboratories, Alexandria, VA). In some experiments, the reaction volume and the volume of the aliquot dequenched were varied as indicated in the figure legends. Where indicated, RRL was heat treated by preincubation at 45 °C 10' prior to addition of the amino acids, RNAsin and RNA.
Cell-free translation with radiochemical labeling was carried out in a similar reaction with 1.2 /iM (1.2 mCi/ml) 35 Smethionine in place of unlabeled methionine. Labeled proteins were separated by SDS-PAGE, and autoradiographs were obtained following fluorography with Enhance (Dupont).
P68 kinase inhibitors
Poly I:C was kindly provided by Michael Katze, University of Washington. 2-aminopurine (Sigma Chemical Co.) was freshly prepared in 50 mM KOH.
RNA analyses RNA was recovered from cell-free translation reactions by digestion in lOmM Tris pH7.8, 5mM EDTA containing 400 /xg/ml proteinase K, 0.5% SDS with 2 ng CAT RNA added to each sample to control for RNA recovery and Northern transfer efficiency. Following phenol'.chloroform extraction and ethanol precipitation, RNA samples were separated on 1 % formaldehyde agarose gels, transferred to nitrocellulose, and hybridized to a 2.1 kb Hindm/SacI fragment from pEQ3 specific for /3-gal and the Hindm/BamHI fragment from pEQ319 specific for CAT.
RESULTS

Enzymatic Cell-free Translation (TVT-MUG) Assay
Published studies using cell-free translation systems demonstrated a strong inhibitory effect of HIV-1 leader sequences (4, 5, 7) . In contrast, the same sequences had little or no apparent translational effect in intact cells (12, 14, 15) . Comparisons of the polysomal distribution of RNAs in RRL and in intact human fibroblasts confirmed that the HIV-1 leader sequences only inhibited translation in RRL (C.R. Degnin and A.P. Geballe, unpublished data).
To facilitate investigation into the basis for the discordant translational effects of the HTV-1 leader in intact cells compared to cell-free lysates, we developed a quantitative cell-free translation assay in which translational efficiency was assessed by measurement of 0-galactosidase (/3-gal) enzymatic activity. As detailed in Materials and Methods, transcripts synthesized in vitro were translated in RRL (heated to 45° for 10' prior to use where indicated [see below]) in the presence of unlabeled amino acids. The translation products were incubated with buffer containing the fluorogenic /3-gal substrate MUG. Because of fluorescence-quenching activity in RRL (data not shown), aliquots of the reactions were dequenched with NaOH and H 2 C^ prior to measuring the fluorescence.
Using a 0-gal transcript without HTV-l leader sequences (pEQ4-RNA, Fig. 1 ), this assay detected the products of translation from as little as 8 ng/ml (in a 12.5 /tl reaction) of /3-gal RNA (Fig. 2) . Importantly, the enzymatic assay was linear with input levels of RNA up to approximately 800 ng/ml before a plateau was reached. For comparison, the same RNA samples were translated in RRL using a standard ^S-methionine labeling assay (Fig. 2B) . The approximately similar sensitivities of the two assays demonstrates that the enzymatic cell-free translation (TVT-MUG) assay is a suitable alternative to the conventional assay. Compared to the 35 S-methionine labeling assay, the IVT-MUG assay has the advantages of being rapid, inexpensive, and easily quantified.
Translational inhibition by HTV-1 leader sequences
Using the IVT-MUG assay, the effect of HTV-1 leader sequences on translation was examined. RNA was transcribed in vitro from the bacteriophage promoter in the plasmid pEQ4 which contains no HTV leader, or in pEQ293, pEQ292, and pEQ3O6 which express transcripts starting at the authentic HTV-1 cap site (+1) and containing 25, 83, or 292 nt, respectively, of HTV leader fused to lacZ (Fig. 1) . Inclusion of the first 25 nt of the HTV-1 leader did not influence cell-free translation compared to RNA with no HTV-1 sequences (Fig. 3) . In contrast inclusion of 83 or 282 nt of the HTV-1 leader at the 5' end of /3-gal transcripts inhibited translation (Fig. 3) . The magnitude of inhibition was similar over a range of RNA concentrations from 260 to 800 ng/ml and was more pronounced with +282 RNA (8-10 fold) compared to +83 RNA (3-4 fold). Because RNA transcribed from pEQ4 and pEQ293 (+25) consistently expressed nearly identical /3-gal activities in multiple experiments (Fig. 3 and data not shown), only data using the +25 RNA is shown in subsequent experiments. Consistent with other reports (4, 5, 7) , these data demonstrate an inhibitory effect of HTV-1 leader sequences on cell-free translation.
The HIV-1 leader stem-loop is required for translational inhibition The stem-loop structure formed by the TAR region of the HTV-1 leader was shown to be important in mediating translational effects in previous studies (4, 5, 8) . Therefore, we analyzed translation of RNAs transcribed from the stem-loop mutants pEQ390, pEQ389, and pEQ388. Destabilizing the TAR hairpin structure by mutation of 8 nt either on the 5' (pEQ390) or on the 3' (pEQ389) side of the stem inactivated the inhibitory signal (Fig. 4) . Restoration of base pairing in the stem by complementary mutations (pEQ388) restored the signal. Thus, the hairpin structure is an essential component of the inhibitory signal. of the HTV-1 leader (compare lanes 2 and 3 to lanes 9-12), these data demonstrate that using our assay conditions, the predominant inhibitory effect of HIV-1 leader sequences is cw-acting. One potential explanation for an apparent decrease in the translational efficiency of +83 and +282 RNA is decreased stability of these transcripts compared to +25 RNA. To investigate this possibility, RNA was extracted from cell-free translation reactions after 0 and 30 minutes of translation. The decrease in /3-gal RNA levels during the 30 minutes of translation was similar between both RNA samples in each mixture (Fig. 5B) . CAT RNA, which was added to each sample at the beginning of the extraction procedure, was comparable in all lanes, demonstrating that recovery and blotting efficiency were consistent among samples. Thus differential translational efficiency rather than stability of RNAs explains the inhibitory effect of HTV leader sequences to +83 or +282.
p68 kinase activation does not account for translational inhibition
Our results demonstrate a cw-acting inhibitory effect of HTV-1 leader sequences to +83 or to +282 on cell-free translation. Other reports revealed that these sequences are capable of activating p68 kinase (5, 8, 18) . While any trans-acting inhibitory effects of HTV-1 leader sequence cannot account for the data shown in Fig. 5 , it is conceivable that HIV-1 RNAs act in cis by activating p68 locally (19, 20) . To determine whether the inhibitory effect is mediated by the p68 kinase, we blocked activation of p68 kinase by adding either 2-aminopurine or high levels of poly I:C to IVT-MUG assays (Fig. 6) . Regardless of the level of 2 aminopurine used, we found that +83 and +282 RNA expressed much less /3-gal than +25 RNA. Similarly, sequences to +83 or +282 inhibited translation in the presence of 25 /ig/ml poly I:C which, contrary to the effects of low concentrations of dsRNA, blocks activation of p68 kinase (5, 7, 8, 21) . The failure of 2-aminopurine or high levels of dsRNA to alter the inhibitory effect of the +83 or +282 leaders suggests that the inhibition under these assay conditions is not due to p68 kinase activation by HTV-1 sequences. Further, these data support the conclusion from data presented above (Fig. 5 ) that the inhibition is not due to dsRNA contaminating our RNA preparations.
Influence of RRL lot variation and heat treatment on translational inhibition by HIV-1 leader sequences
During the course of these studies we noted the magnitude of the inhibitory effect of HTV-1 leader sequences varied substantially among lots of RRL obtained from the same manufacturer. While the HIV-1 leader in +83 RNA and +292 RNA inhibited downstream translation when translated in RRL lot A five-to ten-fold, the same leader inhibited translation only up to two-fold in lot B (Fig. 7, left) . Repeated assays of these and additional lots (data not shown) demonstrated that the level of inhibition by HIV-1 leader sequences was reproducible for a particular lot but varied among lots from less than two-fold to approximately ten-fold. These data suggested that a factor (or factors) required for efficient translation through the HTV-1 leader was present in variable quantities in different lysates. Altering the Mg ++ and K + concentrations in the translation reaction did not change the relative translational efficiencies of the RNAs (data not shown).
We predicted that the activity that is variable among RRL lots might be quite labile, being inadvertently inactivated in some but not all preparations of RRL. To test this hypothesis we heated the RRL prior to the translation reaction. Heating RRL lot B to 45° for 10' disproportionately repressed translation of +83 or + 292 RNA compared to +25 RNA (Fig. 7, middle) , resulting in a markedly greater fold inhibition. Heating lot A also magnified the inhibitory effect of the HIV-1 leader (Fig. 7, middle) . These data suggested that a heat-labile factor is required for efficient translation of +83 and +292 RNA in RRL.
To investigate whether the inefficient translation of +83 and +282 RNAs in RRL lot A (without heat treatment) could be complemented by heat-treated lysate B, RNAs were translated in an equal volume mixture of RRL lot A and heat-treated RRL lot B. The HTV-1 leader still inhibited translation in this mixture (Fig. 7, right) . This result suggests that the factor deficient in RRL lot A is present in lot B but is heat-labile. Consistent with this hypothesis, equivalent results were obtained using either lot A without heat treatment (data not shown) or heat-treated lot B in each of the translation reactions reported (Figures 2-6 ).
DISCUSSION
Initiation of translation of most eukaryotic mRNAs involves loading of the 40s ribosomal subunit and associated factors onto the 5' end (cap site) of the mRNA and subsequent scanning in a 3' direction until an AUG codon is recognized. The 60s ribosomal subunit then joins the complex and polypeptide synthesis begins (reviewed in 22) . Since approximately 290 nt at the 5' end of the HTV-1 genome are present on all spliced and unspliced viral transcripts, signals within this transcript leader have the potential to coordinately regulate the posttranscriptional expression of HIV-1 genes. The investigations reported here were designed to elucidate the basis for conflicting observations of the translational effects of the HTV-1 leader in different systems (4) (5) (6) (7) (8) (9) 12, 14, 15, 18) . In cell-free extracts, the HTV-1 transcript leader has been reported to inhibit translation (4, 7) . While the 5' proximal 25 nt of the HTV-1 leader do not inhibit translation (Fig. 3) , our studies confirm that the 5' proximal 83 nt inhibit translation and that RNAs containing a leader including nearly the entire first exon common to all HTV-1 transcripts are translated even less efficiently (Figs. 3, 5-7) .
Several possible mechanisms may account for the inhibitory effect of the HIV-1 leader. RNA secondary structure near the 5' end of a transcript can block the interactions of the RNA with translation initiation factors and thereby inhibit loading of 40s ribosomal subunits (reviewed in 22). The stem-loop structure of the HTV-1 transcript leader impairs interactions with eIF-4B as detected in cross-linking assays (4). Our results are consistent with this analysis in that mutations which destabilize the stem structure at the 5' end of the HTV-1 leader alleviate the inhibition, while compensatory mutations which restore the stem, restore the inhibition (Fig. 4) . Furthermore, as we demonstrate (Fig. 5) , the inhibition acts predominantly in cis as expected for such a mechanism.
However, other mechanisms may also require a stem-loop RNA structure and act in cis. Activation of p68 kinase results in phosphorylation of the a subunit of eIF-2 which in turn inhibits translational initiation (reviewed in 23). p68 may be activated locally and therefore appear to act in cis (19, 20) . HTV-1 RNA, acting like low levels of dsRNA, can activate p68 kinase (5, 8, 18) . Contrarily, highly purified HTV-1 leader RNA can prevent activation of p68 kinase and thereby preserve efficient initiation of translation (9) . The basis for these contrary effects of the HIV-1 leader on p68 kinase activation is not clear but may be related to differences in quantity or purity of the RNA used in various studies. Under our conditions, translational inhibition occurs independent of p68 kinase activation. Standard inhibitors of p68 kinase activation, 2-aminopurine and high levels of dsRNA (7, 21) , failed to alleviate the inhibition (Fig. 6) .
Despite these results, the HTV-1 leader may activate p68 kinase and inhibit translation in trans. In fact, we observe a decrease in translation of RNAs without the HTV-1 leader when mixed with HTV-1 leader-containing RNAs in Fig. 5 which may reflect p68-mediated trans-acting inhibition. Furthermore, we did not preincubate extracts in the presence of added RNA which may be necessary to elicit activation of p68 (5, 7) .
Another potential mechanism is suggested by studies in Xenopus oocytes, demonstrating that HTV-1 leader-containing RNAs must be modified in the nucleus in the presence of Tat in order to be efficiently translated (11) . Recently, a doublestranded RNA-modifying activity was shown to change an A to an I in the HTV-1 leader in oocyte nuclei in the presence of Tat (24) . Although the impact of this modification on translation is not yet known, it is possible that the inhibitory signal in the HIV-1 leader precludes translation until the signal is modified.
We found that the inhibitory effect of the HTV-1 leader varied from over 10-fold to less than 2-fold in different experiments. Data from another group revealed a similar wide range in inhibition mediated by the HIV-1 leader in RRL. The HTV-1 leader to +83 fused to CAT inhibited translation 200-fold in one report (4) but only 10-fold (5) in another. In our experiments, differences among lots of RRL, all obtained from the same commercial source, accounted for the variable effect (Fig. 7) .
In addition to lot-to-lot variation in the magnitude of inhibition, we discovered that heating RRL prior to the translation reaction magnified the inhibition. The failure of heat-treated lot B RRL to complement lot A (Fig. 7) could be explained if the same factor that is deficient in lot A is also heat-labile. However, further studies will be required to identify and characterize factors required for efficient translation of HTV-1 mRNAs. Of interest, the HTV-1 leader does not inhibit translation at all in extracts derived from the mouse rhabdomyosarcoma cell line Sac" (unpublished data). These extracts may therefore be useful in attempts to complement the translational defects of RRL lot A or heat-treated lot B. The convenience of the IVT-MUG assay should facilitate a biochemical approach to identifying the factor(s) required for efficient translation of HTV-1 mRNAs. Elucidating these factors necessary for translation of HTV-1 transcripts will undoubtedly enrich our understanding of eukaryotic translation in other viral and cellular systems.
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